Ultron Pharma India Private Limited
About Ultron Pharma India Private Limited
Data last updated:
Ultron Pharma India Private Limited was a private limited company based in Bhopal, Madhya Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 February 2015.
The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2015PTC033837. Its GSTIN is 23AABCU7851R1ZP (Madhya Pradesh).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rehana Khan and Farhat Hameed Khan.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 13/14 Housing Board Colony Koh – E – Fiza, Bhopal, Madhya Pradesh, India – 462001.
As per the financials filed for FY 2017, the company reported a revenue of ₹64.74 Lakh. For the same year it recorded a net loss of ₹60.94 Lakh (net margin -94.1%) and EBITDA of -₹59.46 Lakh (EBITDA margin -91.8%).
Company details
Contact details
Ultron Pharma India Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address13/14 Housing Board Colony Koh – E – Fiza, Bhopal, Madhya Pradesh, India – 462001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Ultron Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ultron Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ultron Pharma India Private Limited, buy the company report.
Financials of Ultron Pharma India Private Limited
FY 2017 filings availableUltron Pharma India Private Limited reported revenue of ₹64.74 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹64.74 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹59.46 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹60.94 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -91.8% | ||
| Net Profit Margin | -94.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ultron Pharma India Private Limited, buy the company report.
Board of directors of Ultron Pharma India Private Limited
Ultron Pharma India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rehana Khan Also directs: Caremarque Lifesciences Private Limited | Director | 13 Feb 2015 | 11 Years 8 Months | As last reported |
| Farhat Hameed Khan | Director | 13 Feb 2015 | 11 Years 8 Months | As last reported |
Peer comparison
Ultron Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Irith Chemtech Private Limited | ₹64.97 Lakh (FY 2024) | 11.0% | Dombivli, Maharashtra, India | |||
| Ashoka Coatings Private Limited | ₹64.96 Lakh (FY 2021) | 64.0% | Karnal, Haryana, India | |||
| Chittor Chemical & Minerals Private Limited | ₹64.95 Lakh (FY 2024) | -49.0% | Chittorgarh, Rajasthan, India | |||
| Pulse Chemicals Private Limited | ₹64.89 Lakh (FY 2025) | 0.0% | Anand, Gujarat, India | |||
| Moonbeam International Private Limited | ₹64.75 Lakh (FY 2025) | -78.0% | Ghaziabad, Uttar Pradesh, India | |||
| Ultron Pharma India Private Limitedthis company | ₹64.74 Lakh (FY 2017) | -₹60.94 Lakh | -94.1% | Bhopal, Madhya Pradesh, India | ||
| Nahrung Global Private Limited | ₹64.73 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Netmax Life Sciences Private Limited | ₹64.66 Lakh (FY 2025) | 37.0% | Delhi, India | |||
| Arohi Med-Laboratories Private Limited | ₹64.65 Lakh (FY 2021) | -20.0% | Mumbai, Maharashtra, India | |||
| Vityl Industries Private Limited | ₹64.63 Lakh (FY 2024) | 15.0% | Ahmedabad, Gujarat, India | |||
| Aditri Homecare Private Limited | ₹64.47 Lakh (FY 2025) | 90.0% | Kalyan, Maharashtra, India |
To see the full peer comparison of Ultron Pharma India Private Limited, buy the company report.
Auditor
Ultron Pharma India Private Limited is audited by B C P JAIN AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B C P JAIN AND COMPANY | FY 2017 | 000802C |
Shareholding
The shareholding of Ultron Pharma India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ultron Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ultron Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ultron Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ultron Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCU7851R1ZP | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ultron Pharma India Private Limited, buy the company report.
Recent activity
Ultron Pharma India Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Farhat Hameed Khan was appointed as Director on 13 Feb 2015.
Frequently asked questions
Ultron Pharma India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ultron Pharma India was a private limited company based in Bhopal, Madhya Pradesh, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 February 2015 and is registered under CIN U24230MP2015PTC033837. The company has been struck off by the Registrar of Companies and is no longer operational.
Ultron Pharma India had 2 directors:
- Rehana Khan - Director
- Farhat Hameed Khan - Director
The CIN (Corporate Identification Number) of Ultron Pharma India is U24230MP2015PTC033837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ultron Pharma India is at 1314 Housing Board Colony Koh – E – Fiza, Bhopal, Madhya Pradesh, India – 462001.
Ultron Pharma India was incorporated on 13 February 2015. It is registered with the Registrar of Companies, Gwalior.
The latest financial statements of Ultron Pharma India on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Ultron Pharma India is 23AABCU7851R1ZP, registered in Madhya Pradesh.
Ultron Pharma India operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Ultron Pharma India by revenue are Irith Chemtech Private Limited, Ashoka Coatings Private Limited, Chittor Chemical & Minerals Private Limited, Pulse Chemicals Private Limited, Moonbeam International Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Farhat Hameed Khan was appointed as Director on 13 Feb 2015. Rehana Khan was appointed as Director on 13 Feb 2015.